- Home
- STRA vs NAMS Comparison
STRA vs NAMS Comparison
Compare STRA & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRA
- NAMS
- Stock Information
- Founded
- STRA 2017
- NAMS 2019
- Country
- STRA United States
- NAMS Netherlands
- Employees
- STRA N/A
- NAMS N/A
- Industry
- STRA Other Consumer Services
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- STRA Real Estate
- NAMS Health Care
- Exchange
- STRA Nasdaq
- NAMS Nasdaq
- Market Cap
- STRA 2.1B
- NAMS 2.5B
- IPO Year
- STRA 1996
- NAMS N/A
- Fundamental
- Price
- STRA $78.40
- NAMS $23.60
- Analyst Decision
- STRA Strong Buy
- NAMS Strong Buy
- Analyst Count
- STRA 3
- NAMS 9
- Target Price
- STRA $107.67
- NAMS $41.11
- AVG Volume (30 Days)
- STRA 182.3K
- NAMS 844.8K
- Earning Date
- STRA 07-30-2025
- NAMS 08-06-2025
- Dividend Yield
- STRA 3.05%
- NAMS N/A
- EPS Growth
- STRA 11.28
- NAMS N/A
- EPS
- STRA 4.68
- NAMS N/A
- Revenue
- STRA $1,233,270,000.00
- NAMS $47,140,000.00
- Revenue This Year
- STRA $6.07
- NAMS N/A
- Revenue Next Year
- STRA $5.02
- NAMS N/A
- P/E Ratio
- STRA $16.82
- NAMS N/A
- Revenue Growth
- STRA 5.72
- NAMS 586.97
- 52 Week Low
- STRA $74.28
- NAMS $14.06
- 52 Week High
- STRA $121.60
- NAMS $27.29
- Technical
- Relative Strength Index (RSI)
- STRA 35.25
- NAMS 67.01
- Support Level
- STRA $76.23
- NAMS $22.00
- Resistance Level
- STRA $79.10
- NAMS $24.82
- Average True Range (ATR)
- STRA 1.66
- NAMS 1.21
- MACD
- STRA -0.11
- NAMS 0.25
- Stochastic Oscillator
- STRA 34.66
- NAMS 77.98
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.